Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

Clinical trial NCT00512070 · COMPLETED

Trial details

NCT number: NCT00512070
Sponsor: Seattle Institute for Biomedical and Clinical Research
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Bipolar Disorder Obesity Metabolic Syndrome

Start date: 2007-07-01
Primary completion: 2010-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.